MB

Matthew Bernett

XE Xencor: 97 patents #2 of 104Top 2%
AB AbbVie: 3 patents #535 of 1,308Top 45%
Genentech: 1 patents #1,597 of 2,392Top 70%
Overall (All Time): #14,741 of 4,157,543Top 1%
99
Patents All Time

Issued Patents All Time

Showing 25 most recent of 99 patents

Patent #TitleCo-InventorsDate
12415849 Heterodimeric proteins Gregory Moore, Rumana Rashid, John Desjarlais 2025-09-16
12398207 Heterodimeric antibodies that bind CD3 and CLDN6 Matthew S. Faber, Sung-Hyung Lee, Yoon Kyung Kim, Jing Qi, Kendra N. Avery +4 more 2025-08-26
12378313 Bispecific binding agents binding to CLDN18.2 and CD3 Alex Nisthal, Gregory Moore 2025-08-05
12359002 Heterodimeric antibodies that bind CD3 and tumor antigens Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more 2025-07-15
12239688 IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof John Desjarlais, Rumana Rashid, Rajat Varma, Christine Bonzon 2025-03-04
12234270 IL-12 heterodimeric Fc-fusion proteins John Desjarlais, Rajat Varma, Ke Liu, Nargess Hassanzadeh-Kiabi, Rumana Rashid 2025-02-25
12152076 Bispecific and monospecific antibodies using novel anti-PD-1 sequences Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal +1 more 2024-11-26
12139525 Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains John Desjarlais, Rajat Varma, Suzanne Schubbert, Juan Diaz 2024-11-12
12129309 Heterodimeric antibodies that bind CD3 and CD38 Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal 2024-10-29
12006345 Untargeted and targeted IL-10 Fc-fusion proteins Gregory Moore, Rajat Varma, Yoon Kyung Kim, Rumana Rashid, Alex Nisthal +2 more 2024-06-11
11981717 Engineered IL-2 Fc fusion proteins John Desjarlais, Rajat Varma, Rumana Rashid 2024-05-14
11945880 Heterodimeric antibodies that bind CD3 and tumor antigens Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more 2024-04-02
11932675 PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties John Desjarlais, Michael Hedvat, Rajat Varma, Suzanne Schubbert, Christine Bonzon +4 more 2024-03-19
11859012 Heterodimeric antibodies that bind CD3 and GPC3 Alex Nisthal, Nargess Hassanzadeh-Kiabi, Katrina Bykova, Rajat Varma 2024-01-02
11859011 Heterodimeric antibodies that bind CD3 and tumor antigens Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more 2024-01-02
11851466 Targeted IL-12 heterodimeric Fc-fusion proteins John Desjarlais, Rajat Varma, Ke Liu, Rumana Rashid, Nargess Hassanzadeh-Kiabi +1 more 2023-12-26
11840579 Bispecific antibodies that bind to CD38 and CD3 Seung Chu, Gregory Moore, John Desjarlais 2023-12-12
11814423 Heterodimeric proteins Gregory Moore, Rumana Rashid, John Desjarlais 2023-11-14
11739144 Heterodimeric antibodies that bind CD3 and CLDN6 Matthew S. Faber, Sung-Hyung Lee, Yoon Kyung Kim, Jing Qi, Kendra N. Avery +4 more 2023-08-29
11739145 Bispecific binding agents binding to CLDN18.2 and CD3 Alex Nisthal, Gregory Moore 2023-08-29
11718667 Optimized antibody variable regions Gregory Moore, Rumana Rashid, John Desjarlais 2023-08-08
11673972 Heterodimeric antibodies that bind CD3 and tumor antigens Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more 2023-06-13
11655277 IL-12 heterodimeric Fc-fusion proteins John Desjarlais, Rajat Varma, Ke Liu, Nargess Hassanzadeh-Kiabi, Rumana Rashid 2023-05-23
11634506 Heterodimeric proteins Gregory Moore, Rumana Rashid, John Desjarlais 2023-04-25
11618788 Optimized antibodies that target CD19 Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more 2023-04-04